Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
Antimicrobial Agents and Chemotherapy
|
March 14, 2023
Efavirenz-Based Antiretroviral Therapy but Not Pregnancy Increased Unbound Piperaquine Exposure in Women during Malaria Chemoprevention
Howard Hong, Usman Aslam-Mir, Richard Kajubi, et al.
Plos One
|
May 30, 2020
Determination of piperaquine concentration in human plasma and the correlation of capillary versus venous plasma concentrations
Norah Mwebaza, Vincent Cheah, Camilla Forsman, et al.
Clinical Pharmacology and Therapeutics
|
April 15, 2020
Optimizing Hydroxychloroquine Dosing for Patients With COVID-19: An Integrative Modeling Approach for Effective Drug Repurposing
Maria Garcia-Cremades, Belen P Solans, Emma Hughes, et al.
The Journal of Infectious Diseases
|
November 13, 2018
Comparative Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Malaria in Ugandan Children
Adoke Yeka, Erika Wallender, Ronald Mulebeke, et al.
Clinical Pharmacology and Therapeutics
|
June 8, 2019
Reduced Exposure to Piperaquine, Compared to Adults, in Young Children Receiving Dihydroartemisinin-Piperaquine as Malaria Chemoprevention
Meghan E Whalen, Richard Kajubi, Nona Chamankhah, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 5, 2021
Piperaquine-Induced QTc Prolongation Decreases With Repeated Monthly Dihydroartemisinin-Piperaquine Dosing in Pregnant Ugandan Women
Emma Hughes, Erika Wallender, Richard Kajubi, et al.
The Journal of Infectious Diseases
|
December 23, 2017
Predicting Optimal Dihydroartemisinin-Piperaquine Regimens to Prevent Malaria During Pregnancy for Human Immunodeficiency Virus-Infected Women Receiving Efavirenz
Erika Wallender, Katarina Vucicevic, Prasanna Jagannathan, et al.
The Journal of Infectious Diseases
|
May 23, 2023
Seasonal Malaria Chemoprevention Drug Levels and Drug Resistance Markers in Children With or Without Malaria in Burkina Faso: A Case-Control Study
Michelle E Roh, Issaka Zongo, Alassane Haro, et al.
Malaria Journal
|
August 1, 2024
Malaria community case management usage and quality of malaria care in a moderate Plasmodium falciparum burden region of Chadiza District, Zambia
Erika Wallender, Bupe Kabamba, Marie-Reine I Rutagwera, et al.
Malaria Journal
|
June 16, 2026
The Malaria Vaccine Implementation Programme reduced clinical malaria in Kenya, 2020 to 2022 : Impact evaluation with predictive time-series models of routine surveillance data
John A Painter, Erika Wallender, Andrew N Hill, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
Antimicrobial Agents and Chemotherapy
|
March 14, 2023
Efavirenz-Based Antiretroviral Therapy but Not Pregnancy Increased Unbound Piperaquine Exposure in Women during Malaria Chemoprevention
Howard Hong, Usman Aslam-Mir, Richard Kajubi, et al.
Plos One
|
May 30, 2020
Determination of piperaquine concentration in human plasma and the correlation of capillary versus venous plasma concentrations
Norah Mwebaza, Vincent Cheah, Camilla Forsman, et al.
Clinical Pharmacology and Therapeutics
|
April 15, 2020
Optimizing Hydroxychloroquine Dosing for Patients With COVID-19: An Integrative Modeling Approach for Effective Drug Repurposing
Maria Garcia-Cremades, Belen P Solans, Emma Hughes, et al.
The Journal of Infectious Diseases
|
November 13, 2018
Comparative Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Malaria in Ugandan Children
Adoke Yeka, Erika Wallender, Ronald Mulebeke, et al.
Clinical Pharmacology and Therapeutics
|
June 8, 2019
Reduced Exposure to Piperaquine, Compared to Adults, in Young Children Receiving Dihydroartemisinin-Piperaquine as Malaria Chemoprevention
Meghan E Whalen, Richard Kajubi, Nona Chamankhah, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 5, 2021
Piperaquine-Induced QTc Prolongation Decreases With Repeated Monthly Dihydroartemisinin-Piperaquine Dosing in Pregnant Ugandan Women
Emma Hughes, Erika Wallender, Richard Kajubi, et al.
The Journal of Infectious Diseases
|
December 23, 2017
Predicting Optimal Dihydroartemisinin-Piperaquine Regimens to Prevent Malaria During Pregnancy for Human Immunodeficiency Virus-Infected Women Receiving Efavirenz
Erika Wallender, Katarina Vucicevic, Prasanna Jagannathan, et al.
The Journal of Infectious Diseases
|
May 23, 2023
Seasonal Malaria Chemoprevention Drug Levels and Drug Resistance Markers in Children With or Without Malaria in Burkina Faso: A Case-Control Study
Michelle E Roh, Issaka Zongo, Alassane Haro, et al.
Malaria Journal
|
August 1, 2024
Malaria community case management usage and quality of malaria care in a moderate Plasmodium falciparum burden region of Chadiza District, Zambia
Erika Wallender, Bupe Kabamba, Marie-Reine I Rutagwera, et al.
Malaria Journal
|
June 16, 2026
The Malaria Vaccine Implementation Programme reduced clinical malaria in Kenya, 2020 to 2022 : Impact evaluation with predictive time-series models of routine surveillance data
John A Painter, Erika Wallender, Andrew N Hill, et al.
Page
of 3